The University of Sheffield, The United Kingdom
Lecturing and Teaching:
This unit is designed for biomedical scientists and clinicians engaged in genetics. Biologists still think our genome is stable, yet the evidence shows that it suffers from breaking and sealing all the time. There are approximately 10,000 DNA breaks per cell per minutes. Breaking and sealing the DNA is a fine balance, which if lost leads to diseases such as neurological disorders and cancer. It is critical to be able to read and understand the composition of an entire genome as you would read a book from beginning to end. In this course, we will see how our genome is kept stable, techniques to read and understand its instability and the consequences they might have on human health.
Learning Outcomes:
Learning and Teaching Resources:
The reading material can be found in this link:
https://www.dropbox.com/sh/1ruw5w61mpw5vu1/AABDPD_u5MspAnox4KLKnakBa?dl=0
Tasks and Timeline:
Module 1 (Week 1) Finding the Sources and Forms of DNA Breaks
This course begins with a series of classes illustrating the diverse nature of genomic breaks, the good, the bad and the ugly.
Module 2 (Week 2) Breaking and Sealing the Human Genome: A Question of balance – Clinical Case Study 1
In this course, we will see how the balance is tightly kept between breaking and sealing the human genome with real examples from the clinic. We will further learn how scientists collected the experimental evidence to reach to conclusions.
Module 3 (Week 3) Breaking and Sealing the Human Genome: A Question of balance – Clinical Case Study 2
Once we have learned how the imbalance could lead to disease, we will learn how scientists employed the same techniques to discover the cause of more human disorders resulting from defective DNA repair.
Module 4 (Week 4) The Beneficial Aspects of Inducing DNA Damage
In the previous course we learned how the imbalance between breaking and sealing our DNA causes disease. Here, we will learn why and how clinicians intentionally induce DNA damage to treat cancer. We will learn an important clinical concept called: Synthetic Lethality.
Module 5 (Week 5) Inflammation: The Silent Killer
Here, we will learn how DNA damage modulates the inflammatory response and mechanisms of tackling this connection to suppress inflammation.
Total Number of Modules | 5 |
Time duration of Each module | 45 minutes |
Total Program Cost | $750 |
This program allows Merit Applications. This program allows merit-based applications for virtual and onsite clinical and research programs. If you are successfully awarded under this category, Trialect or the host mentor will cover the tuition fee only. All applications will be evaluated based on merit. Due to the high level of competition, the chances of being selected under the merit category are quite limited.
This unit is designed for biomedical scientists and clinicians engaged in genetics.
Host Name: Professor Sherif El-Khamisy
Affiliation: The University of Sheffield
Address: The University of Sheffield, Western Bank ,Sheffield, S10 2TN, UK
Website URL: https://www.sheffield.ac.uk/mbb/staff/sherifelkhamisy
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Dec 1st, 2024
Duration | Fee |
---|---|
2 weeks | $875.00 |
6 weeks | $1,500.00 |
12 weeks | $2,750.00 |
This program allows Merit Applications. This program allows merit-based applications for virtual and onsite clinical and research programs. If you are successfully awarded under this category, Trialect or the host mentor will cover the tuition fee only. All applications will be evaluated based on merit. Due to the high level of competition, the chances of being selected under the merit category are quite limited.
This unit is designed for biomedical scientists and clinicians engaged in genetics.
Host Name: Professor Sherif El-Khamisy
Affiliation: The University of Sheffield
Address: The University of Sheffield, Western Bank ,Sheffield, S10 2TN, UK
Website URL: https://www.sheffield.ac.uk/mbb/staff/sherifelkhamisy
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.
Commonly asked questions about this program from the host and other attendees.